Cargando…

A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology

Squamous cell carcinoma represents the most common cancer affecting the oral cavity. At the University of Naples “Federico II”, two different antibiotic protocols were used in patients undergoing oral mucosa cancer surgery from 2006 to 2018. From 2011, there was a shift; the combination of Cefazolin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciardi, Carlo, Orabona, Giovanni Dell’Aversana, Picone, Ilaria, Latessa, Imma, Fiorillo, Antonella, Sorrentino, Alfonso, Triassi, Maria, Improta, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469470/
https://www.ncbi.nlm.nih.gov/pubmed/34574768
http://dx.doi.org/10.3390/ijerph18189846
_version_ 1784573940049379328
author Ricciardi, Carlo
Orabona, Giovanni Dell’Aversana
Picone, Ilaria
Latessa, Imma
Fiorillo, Antonella
Sorrentino, Alfonso
Triassi, Maria
Improta, Giovanni
author_facet Ricciardi, Carlo
Orabona, Giovanni Dell’Aversana
Picone, Ilaria
Latessa, Imma
Fiorillo, Antonella
Sorrentino, Alfonso
Triassi, Maria
Improta, Giovanni
author_sort Ricciardi, Carlo
collection PubMed
description Squamous cell carcinoma represents the most common cancer affecting the oral cavity. At the University of Naples “Federico II”, two different antibiotic protocols were used in patients undergoing oral mucosa cancer surgery from 2006 to 2018. From 2011, there was a shift; the combination of Cefazolin plus Clindamycin as a postoperative prophylactic protocol was chosen. In this paper, a health technology assessment (HTA) is performed by using the Six Sigma and DMAIC (Define, Measure, Analyse, Improve, Control) cycle in order to compare the performance of the antibiotic protocols according to the length of hospital stay (LOS). The data (13 variables) of two groups were collected and analysed; overall, 136 patients were involved. The American Society of Anaesthesiologist score, use of lymphadenectomy or tracheotomy and the presence of infections influenced LOS significantly (p-value < 0.05) in both groups. Then, the groups were compared: the overall difference between LOS of the groups was not statistically significant, but some insights were provided by comparing the LOS of the groups according to each variable. In conclusion, in light of the insights provided by this study regarding the comparison of two antibiotic protocols, the utilization of DMAIC cycle and Six Sigma tools to perform HTA studies could be considered in future research.
format Online
Article
Text
id pubmed-8469470
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84694702021-09-27 A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology Ricciardi, Carlo Orabona, Giovanni Dell’Aversana Picone, Ilaria Latessa, Imma Fiorillo, Antonella Sorrentino, Alfonso Triassi, Maria Improta, Giovanni Int J Environ Res Public Health Article Squamous cell carcinoma represents the most common cancer affecting the oral cavity. At the University of Naples “Federico II”, two different antibiotic protocols were used in patients undergoing oral mucosa cancer surgery from 2006 to 2018. From 2011, there was a shift; the combination of Cefazolin plus Clindamycin as a postoperative prophylactic protocol was chosen. In this paper, a health technology assessment (HTA) is performed by using the Six Sigma and DMAIC (Define, Measure, Analyse, Improve, Control) cycle in order to compare the performance of the antibiotic protocols according to the length of hospital stay (LOS). The data (13 variables) of two groups were collected and analysed; overall, 136 patients were involved. The American Society of Anaesthesiologist score, use of lymphadenectomy or tracheotomy and the presence of infections influenced LOS significantly (p-value < 0.05) in both groups. Then, the groups were compared: the overall difference between LOS of the groups was not statistically significant, but some insights were provided by comparing the LOS of the groups according to each variable. In conclusion, in light of the insights provided by this study regarding the comparison of two antibiotic protocols, the utilization of DMAIC cycle and Six Sigma tools to perform HTA studies could be considered in future research. MDPI 2021-09-18 /pmc/articles/PMC8469470/ /pubmed/34574768 http://dx.doi.org/10.3390/ijerph18189846 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ricciardi, Carlo
Orabona, Giovanni Dell’Aversana
Picone, Ilaria
Latessa, Imma
Fiorillo, Antonella
Sorrentino, Alfonso
Triassi, Maria
Improta, Giovanni
A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
title A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
title_full A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
title_fullStr A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
title_full_unstemmed A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
title_short A Health Technology Assessment in Maxillofacial Cancer Surgery by Using the Six Sigma Methodology
title_sort health technology assessment in maxillofacial cancer surgery by using the six sigma methodology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469470/
https://www.ncbi.nlm.nih.gov/pubmed/34574768
http://dx.doi.org/10.3390/ijerph18189846
work_keys_str_mv AT ricciardicarlo ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT orabonagiovannidellaversana ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT piconeilaria ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT latessaimma ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT fiorilloantonella ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT sorrentinoalfonso ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT triassimaria ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT improtagiovanni ahealthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT ricciardicarlo healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT orabonagiovannidellaversana healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT piconeilaria healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT latessaimma healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT fiorilloantonella healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT sorrentinoalfonso healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT triassimaria healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology
AT improtagiovanni healthtechnologyassessmentinmaxillofacialcancersurgerybyusingthesixsigmamethodology